Peregrine Pharmaceuticals Inc.’s (NASDAQ:PPHM) second quarter fiscal 2011 loss of 13 cents per share was wider than the loss of 12 cents indicated by the Zacks Consensus Estimate. The biopharmaceutical company reported a loss of 6 cents per share in the year-ago quarter. The wider loss was primarily attributable to lower revenues and higher expenses [...]